Knockout of the GIP receptor blocks LTP potentiation in the CA1 area of the hippocampus and induces synaptic dysfunction in mice [105]
But what we are seeing is that GLP-1 coverage is getting more accessible for specific conditions sleep apnea, diabetes, extremely high BMI or a combination of these things but for other conditions, coverage is probably going to get more restrictive
Training depletes glycogen stores and creates micro-damage in muscle tissue that requires protein and calories to repair
I verify sources, protocol interpretation, and final judgments personally
One such medical advancement is Semaglutide GLP-1, a medication traditionally used to treat type 2 diabetes and recently found effective in assisting with weight loss
If your symptoms are not improving, are getting worse, or feel severe in any way, contact your healthcare provider right away rather than waiting it out.